Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Nerpentin vs Neurontin (Gabapentin) in Healthy Subjects
NCT04805827Phase 1Completed
- Sponsor
- PharmaGuide
- Start
- Feb 2021
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of gabapentin in epilepsy and neuropathic pain (2 arms), sponsored by PharmaGuide. Primary endpoints: Peak Plasma Concentration and Area under the plasma concentration versus time curve. Started Feb 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
epilepsyneuropathic pain
Beyond the preview
Go deeper on NCT04805827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04805827.